The IPOX® Watch: M&A Research Institute (9552 JP)
COMPANY DESCRIPTION
M&A Research Institute Holdings Inc., also known as Masouken, headquartered in Tokyo, Japan, operates as a specialized intermediary in the mergers and acquisitions (M&A) market, focusing primarily on small and medium-sized enterprises (SMEs). The company was founded in 2018 by 27-year old Shunsaku Sagami, who has rapidly ascended to become Japan's youngest billionaire, thanks to the remarkable success and innovative approach of his firm. M&A Research Institute Holdings Inc. leverages cutting-edge artificial intelligence technology to match potential buyers with companies. This technology is particularly aimed at businesses at risk of closure due to the aging of their owners and the absence of successors, a common issue among Japanese SMEs.
BUSINESS MODEL
M&A Research Institute generates revenue through a success-fee model, where fees are charged upon the successful conclusion of M&A transactions, ensuring that the company's interests are closely aligned with those of its clients. The company advertises the fast turnover of its deals, averaging 6.2 months to completion.
Additionally, M&A Research Institute Holdings has diversified its revenue streams by venturing into asset management, offering financial advice and investment solutions to business owners who have successfully exited their companies.
IPO HISTORY
On 06/28/2022, M&A Research Institute Holdings Inc. began trading on the Tokyo Main Exchange. The firm offered a 25% float of 4.16 million shares at ¥1330 per share, at the top of its expected price range (¥1210 - ¥1330), raising ¥6.36 billion ($50.27 million) with its over-allotment option fully exercised, resulting in a market capitalization of ¥25.47 billion ($201.28 million). The offer was managed by Nomura Securities Co. Ltd as the lead underwriter. The shares closed the first day higher at ¥2292 (+72.33%).
M&A Research Institute was included in the IPOX® Japan Index (IPJP) on 9/19/2022 and has gained +243.26% since addition.
The firm gained +39.34% since its inclusion in the IPOX® International Index (ETF: FPXI US) on 12/18/2023, and currently weighs ca. 0.65% of the portfolio.
